DGAP-News: Helix BioPharma Corp. Announces Q1 2012 Results
Helix BioPharma Corp. / Key word(s): Interim Report
13.01.2012 23:39
—————————————————————————
AURORA, ON — (Marketwire) — 01/13/12 — Helix BioPharma Corp.
(TSX: HBP) (NYSE Amex: HBP) (FRANKFURT: HBP), a biopharmaceutical
company developing drug candidates for the prevention and treatment
of cancer, today announced financial results for the quarter ended
October 31, 2011.
HIGHLIGHTS
DOS47/L-DOS47:
— As previously announced, during
